algernon

N/A

Report date: 2025/03/18 18:04:03
NME

Base Information

Drug Namealgernon
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDual-specificity tyrosine-phosphorylation regulated kinase 1A inhibitors
TargetsDual-specificity tyrosine-phosphorylation regulated kinase 1A
Therapy Area/IndicationsDown Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKyoto University
China Registration ClassN/A

Develop Information

Active CompaniesKyoto University
Inactive CompaniesN/A
Active IndicationsDown Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A